Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety

Name: Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety
SKU: 7823
Price: 30.00 USD
Availability: InStock

$30.00

Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety and Safety
By Matthew T. Morris, Sandip P. Tarpada

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 47 No. 2 Articles - 2017 Tags: antipsychotic-medication, efficacy-and-safety, evidence-based-medicine, matthew-t-morris, paliperidone-palmitate, psychopharmacology, sandip-p-tarpada, schizophrenia

Description

Description

EVIDENCE-BASED MEDICINE
Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety
and Safety
By Matthew T. Morris, Sandip P. Tarpada

42-52_PB-47-2-2017_Morris

Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety

Description

Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

Mikael Landén, MD, PhD: Treatment Refractory Psychosis Remitted Upon Treatment with Continuous Positive Airway Pressure: A Case Report

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Title

Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety

Description

Related products

Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

Mikael Landén, MD, PhD: Treatment Refractory Psychosis Remitted Upon Treatment with Continuous Positive Airway Pressure: A Case Report

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Ethical Issues In Schizophrenia: Considerations for Treatment and Research

Title